This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
How Much Upside is Left in Ingevity (NGVT)? Wall Street Analysts Think 30%
by Zacks Equity Research
The mean of analysts' price targets for Ingevity (NGVT) points to a 30% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Ingevity (NGVT) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Ingevity (NGVT) delivered earnings and revenue surprises of 21.51% and 12.51%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Ingevity (NGVT) Wraps Up Expansion of Polyols Production
by Zacks Equity Research
The expansion at Ingevity's (NGVT) plant in DeRidder increases its global capacity for producing polyols by 40%.
Ingevity (NGVT) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Ingevity (NGVT) Gains on Demand Strength and Growth Actions
by Zacks Equity Research
Ingevity (NGVT) benefits from strength in its engineered polymers and industrial specialties businesses and actions to drive growth.
Why Ingevity (NGVT) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Ingevity (NGVT) Looks Ripe for Bottom Fishing
by Zacks Equity Research
Ingevity (NGVT) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Ingevity (NGVT) Up 0.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Industry Outlook Highlights Livent, Daqo New Energy, Ingevity and Hawkins
by Zacks Equity Research
Livent, Daqo New Energy, Ingevity and Hawkins have been highlighted in this Industry Outlook article.
4 Stocks to Buy From the Promising Chemical Specialty Industry
by Anindya Barman
The Zacks Chemicals Specialty industry is poised to benefit from higher demand across major end-use markets. LTHM, DQ, NGVT and HWKN are set to gain from the favorable industry fundamentals and strategic actions to counter cost inflation.
Why You Should Add Ingevity (NGVT) Stock to Your Portfolio
by Zacks Equity Research
Ingevity (NGVT) rides on solid demand and higher selling prices in engineered polymers and industrial specialties businesses and its growth actions.
Wall Street Analysts Think Ingevity (NGVT) Could Surge 25%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 25.3% upside potential for Ingevity (NGVT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Why Ingevity (NGVT) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is Mercer International (MERC) Outperforming Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how Mercer International (MERC) and Ingevity (NGVT) have performed compared to their sector so far this year.
Ingevity's (NGVT) Earnings and Sales Top Estimates in Q2
by Zacks Equity Research
Ingevity (NGVT) benefits from actions to increase prices to offset inflationary cost pressures in Q2.
How Much Upside is Left in Ingevity (NGVT)? Wall Street Analysts Think 31%
by Zacks Equity Research
The mean of analysts' price targets for Ingevity (NGVT) points to a 30.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Ingevity (NGVT) Just Reclaimed the 200-Day Moving Average
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 200-day simple moving average. How should investors react?
Ingevity (NGVT) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Ingevity (NGVT) delivered earnings and revenue surprises of 2.98% and 3.30%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights Ingevity, Cabot, Livent, Albemarle and Air Products and Chemicals
by Zacks Equity Research
Ingevity, Cabot, Livent, Albemarle and Air Products and Chemicals are part of Zacks top Analyst Blog.
Can Ingevity (NGVT) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Ingevity (NGVT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Intel's (INTC) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Intel (INTC) misses second-quarter revenue and earnings estimates due to a decline in revenues of Client Computing Group and Datacenter and AI Group.
5 Chemical Stocks Set to Pull Off a Beat This Earnings Season
by Anindya Barman
Strong end-market demand and benefits of self-help actions are likely to have been reflected in the performance of Ingevity (NGVT), Cabot (CBT), Livent (LTHM), Albemarle (ALB) and Air Products (APD).
Minerals Technologies (MTX) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Minerals Technologies (MTX) delivered earnings and revenue surprises of 2.74% and 5.34%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Silicon Motion (SIMO) Q2 Earnings Beat Estimates, Revenues Lag
by Zacks Equity Research
Despite healthy earnings growth due to solid demand trends, Silicon Motion Technology (SIMO) misses second-quarter revenue estimates.
Element Solutions (ESI) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Element Solutions (ESI) delivered earnings and revenue surprises of 2.70% and 0.10%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?